TriangleNCT02581007 · OUTCOME
Graft Rejection
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 100 days
What was measured
Measurement of donor cells vs. recipient cells
Groups in this outcome
Reduced-Intensity Mismatched Transplant
Fludarabine, Melphalan \& Post-transplant cyclophosphamide Fludarabine: fludarabine (30mg/m2) given every day starting on Day -6 through Day -2; Melphalan Cyclophosphamide: cyclophosphamide (50mg/kg) given every day starting on Day 3 through Day 4. peripheral blood stem cell transplant
| Group | Source count |
|---|---|
| Reduced-Intensity Mismatched Transplant | 25 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Reduced-Intensity Mismatched Transplant | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 3
- denoms
- counts
- group Id
- OG000
- value
- 25
- units
- Participants
- description
- Measurement of donor cells vs. recipient cells
- groups
- description
- Fludarabine, Melphalan \& Post-transplant cyclophosphamide Fludarabine: fludarabine (30mg/m2) given every day starting on Day -6 through Day -2; Melphalan Cyclophosphamide: cyclophosphamide (50mg/kg) given every day starting on Day 3 through Day 4. peripheral blood stem cell transplant
- id
- OG000
- title
- Reduced-Intensity Mismatched Transplant
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- 100 days
- title
- Graft Rejection
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice